DURHAM, NC, January 8, 2025 – CREO, the preferred consultancy to the world’s most promising life sciences companies seeking to improve human health, announced today four leadership appointments designed to support the company’s continued growth.
Announced in September 2023, CREO’s strategic recapitalization from Grant Avenue Capital has accelerated its expansion in strategy, technology, and commercialization services to life sciences and healthcare organizations. To position the company for further growth, the new appointments include the following:
- Mike Townley, CREO’s Co-Founder and President, has transitioned to a full-time role as CREO’s Chief Commercial Officer. In this capacity, Mike has assumed responsibility for driving business development and sales excellence across CREO’s rapidly expanding service portfolio, geographic footprint, and client base.
- Connie Pearcy, previously CREO’s Senior Managing Director, has been named the company’s first Chief Operating Officer. As CREO’s third employee, Connie has been instrumental in growing the organization and delighting its customers throughout the company’s history. With this appointment, she has assumed responsibility for all CREO service delivery.
- Bob Riefer, Managing Director, has been appointed practice area leader for all growth acceleration services. Bob’s deep consulting background and industry expertise make him an ideal leader for continuing CREO’s growth in value-creation engagements, including strategy, M&A, and product commercialization services.
- Roger Davy, Managing Director, has been appointed practice area leader for all technology services. With an extensive career in information technology and digital transformation, Roger has a long track record of success in areas such as enterprise and scientific IT, cybersecurity, and data sciences.
“I am thrilled to recognize these leaders in our company,” said Susan Acker-Walsh, CEO and Co-Founder of CREO. “In addition to enabling me to spend more time focusing on the future of our company, these leaders offer market-proven expertise to every client.”
CREO is an award-winning management consulting and advisory services firm specializing in value creation in growth-oriented life sciences and healthcare businesses. Since its founding in 2015, CREO has generated strong market momentum, placing numerous times on Inc. 5000 Fastest-Growing Companies, Inc. Regionals Mid-Atlantic Fastest-Growing Companies, and the Triangle Business Journal’s Fast 50 list.
“It’s an amazing milestone,” said Mike Townley, Co-Founder and Chief Commercial Officer. “Our people are the special sauce at CREO. We are fortunate to have such a powerful mix of people working with clients that are making a healthier world each day.”
About CREO
CREO is the preferred consultancy to the world’s most promising companies seeking to improve human health. We accelerate growth and value creation for life sciences, healthcare, and private equity portfolio companies worldwide through tailored consulting and operating solutions. With deep expertise in strategic planning, M&A, product commercialization, IT enablement, data sciences, and regulatory compliance, CREO has helped hundreds of organizations enhance business performance and advance clinical innovations. Founded in 2015 and headquartered in North Carolina’s Research Triangle Park, CREO is committed to making a better, healthier world. Visit us at www.creoconsulting.com.
